Dumping Syndrome Terminated Phase Trials for Rifaximin (DB01220)

Also known as: Syndromes, Dumping

IndicationStatusPhase
DBCOND0000855 (Dumping Syndrome)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02836353Metabolic Consequences of Gastrointestinal SurgeryDiagnostic